These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38558459)

  • 21. Activation of Blood Coagulation in Two Prototypic Autoimmune Skin Diseases: A Possible Link with Thrombotic Risk.
    Cugno M; Tedeschi A; Borghi A; Bucciarelli P; Asero R; Venegoni L; Griffini S; Grovetti E; Berti E; Marzano AV
    PLoS One; 2015; 10(6):e0129456. PubMed ID: 26057532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral eosinophilia in bullous pemphigoid: prevalence and influence on the clinical manifestation.
    Kridin K
    Br J Dermatol; 2018 Nov; 179(5):1141-1147. PubMed ID: 29663327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunomodulator Galectin-9 is Increased in Blood and Skin of Patients with Bullous Pemphigoid.
    Pruessmann J; Pruessmann W; Holtsche MM; Linnemann B; Hammers CM; van Beek N; Zillikens D; Schmidt E; Sadik CD
    Acta Derm Venereol; 2021 Mar; 101(3):adv00419. PubMed ID: 33606034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NET Formation in Bullous Pemphigoid Patients With Relapse Is Modulated by IL-17 and IL-23 Interplay.
    Giusti D; Bini E; Terryn C; Didier K; Le Jan S; Gatouillat G; Durlach A; Nesmond S; Muller C; Bernard P; Antonicelli F; Pham BN
    Front Immunol; 2019; 10():701. PubMed ID: 31019514
    [No Abstract]   [Full Text] [Related]  

  • 25. Bullous pemphigoid: a cause of peripheral blood eosinophilia.
    Bushkell LL; Jordon RE
    J Am Acad Dermatol; 1983 May; 8(5):648-51. PubMed ID: 6345605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic possibilities of specific fibrin(ogen) degradation products in relation to venous thromboembolism.
    Haas FJ; Schutgens RE; Biesma DH; Laterveer RH; Kluft C
    Blood Coagul Fibrinolysis; 2013 Apr; 24(3):297-304. PubMed ID: 23187785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Relationship between clinical findings of patients with bullous pemphigoid and antigens recognized by their circulating antibasement membrane zone antibodies].
    Gary A; Carvalho P; Louison JB; Helot MF; Gilbert D; Bernard P; Roujeau JC; Bedane C; Delaporte E; Vaillant L; Dreno B; Saiag P; Tancrede-Bohin E; Plantin P; D'Incan M; Sassolas B; Lok C; Labeille B; Pauwels C; Chosidow O; Picard C; Loche F; Guillaume JC; Joly P
    Ann Dermatol Venereol; 2004 Apr; 131(4):333-7. PubMed ID: 15258506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating bullous pemphigoid autoantibodies in the setting of negative direct immunofluorescence findings for bullous pemphigoid: A single-center retrospective review.
    Wang M; Lehman JS; Camilleri MJ; Drage LA; Wieland CN
    J Am Acad Dermatol; 2019 Aug; 81(2):472-479. PubMed ID: 30928465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eosinophil Cationic Protein (ECP), a predictive marker of bullous pemphigoid severity and outcome.
    Giusti D; Gatouillat G; Le Jan S; Plée J; Bernard P; Antonicelli F; Pham BN
    Sci Rep; 2017 Jul; 7(1):4833. PubMed ID: 28684769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of serum markers of cellular immune activation in patients with bullous pemphigoid.
    Bieber K; Ernst AL; Tukaj S; Holtsche MM; Schmidt E; Zillikens D; Ludwig RJ; Kasperkiewicz M
    Exp Dermatol; 2017 Dec; 26(12):1248-1252. PubMed ID: 28500685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased coexpression of eotaxin and interleukin 5 in bullous pemphigoid.
    Shrikhande M; Hunziker T; Braathen LR; Pichler WJ; Dahinden CA; Yawalkar N
    Acta Derm Venereol; 2000; 80(4):277-80. PubMed ID: 11028861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Peripheral Blood and Cutaneous Eosinophils With Bullous Pemphigoid Disease Severity and Treatment Outcomes.
    Garrido PM; Aguado-Lobo M; Espinosa-Lara P; Soares-Almeida L; Filipe P
    Actas Dermosifiliogr; 2022 Oct; 113(9):881-887. PubMed ID: 35659610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High level of thymus and activation-regulated chemokine in blister fluid and sera of patients with bullous pemphigoid.
    Kakinuma T; Wakugawa M; Nakamura K; Hino H; Matsushima K; Tamaki K
    Br J Dermatol; 2003 Feb; 148(2):203-10. PubMed ID: 12588369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The levels of soluble ST2 in sera and bullous fluid from patients with bullous pemphigoid.
    Wakatabi K; Komine M; Meephansan J; Matsuyama Y; Tsuda H; Tominaga S; Ohtsuki M
    Eur J Dermatol; 2012; 22(3):333-6. PubMed ID: 22494834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum soluble CD200 level was higher in patients with bullous pemphigoid during the active phase of the disease than for healthy individuals.
    Akman-Karakaş A; Yalcin AD; Koç S; Gumuslu S; Ergun E; Genc GE; Ongut G; Uzun S; Alpsoy E
    Clin Lab; 2014; 60(7):1237-40. PubMed ID: 25134396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bullous pemphigoid with hyperkeratosis and palmoplantar keratoderma: Three cases.
    Fania L; Didona D; Pacifico V; Mariotti F; De Luca N; Abeni D; Mazzanti C; Di Zenzo G; Didona B
    J Dermatol; 2018 Sep; 45(9):1135-1140. PubMed ID: 30007013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eosinophil-derived galectin-10 upregulates matrix metalloproteinase expression in bullous pemphigoid blisters.
    Sato T; Chiba T; Nakahara T; Watanabe K; Sakai S; Noguchi N; Noto M; Ueki S; Kono M
    J Dermatol Sci; 2023 Oct; 112(1):6-14. PubMed ID: 37640566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bullous pemphigoid, an ultrastructural study of the inflammatory response: eosinophil, basophil and mast cell granule changes in multiple biopsies from one patient.
    Dvorak AM; Mihm MC; Osage JE; Kwan TH; Austen KF; Wintroub BU
    J Invest Dermatol; 1982 Feb; 78(2):91-101. PubMed ID: 7035575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deposition of eosinophil granule proteins precedes blister formation in bullous pemphigoid. Comparison with neutrophil and mast cell granule proteins.
    Borrego L; Maynard B; Peterson EA; George T; Iglesias L; Peters MS; Newman W; Gleich GJ; Leiferman KM
    Am J Pathol; 1996 Mar; 148(3):897-909. PubMed ID: 8774144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased serum levels of interleukin (IL)-5, IL-6 and IL-8 in bullous pemphigoid.
    Inaoki M; Takehara K
    J Dermatol Sci; 1998 Jan; 16(2):152-7. PubMed ID: 9459128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.